S61 Onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy type 1 (SMA1): preliminary pulmonary and ventilatory findings from the phase 3 study (STR1VE)

التفاصيل البيبلوغرافية
العنوان: S61 Onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy type 1 (SMA1): preliminary pulmonary and ventilatory findings from the phase 3 study (STR1VE)
المؤلفون: Shell, R, Day, JW, Chiriboga, CA, Crawford, TO, Darras, BT, Finkel, RS, Connolly, AM, Iannaccone, ST, Kuntz, NL, Peña, LDM, Shieh, PB, Smith, EC, Kausar, I, Schultz, M, Feltner, DE, Ogrinc, FG, Macek, TA, Kernbauer, E, L’Italien, J, Sproule, DM, Kaspar, BK, Mendell, JR
المصدر: Diagnostic and therapeutic advances in paediatrics ; page A42.1-A42
بيانات النشر: BMJ Publishing Group Ltd and British Thoracic Society
سنة النشر: 2019
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/thorax-2019-btsabstracts2019.67
DOI: 10.1136/thorax-2019-BTSabstracts2019.67
الاتاحة: http://dx.doi.org/10.1136/thorax-2019-btsabstracts2019.67
https://syndication.highwire.org/content/doi/10.1136/thorax-2019-BTSabstracts2019.67
رقم الانضمام: edsbas.42C8A357
قاعدة البيانات: BASE